GlassScriptPhysician profile
Adeline Dixon
NPI 1770215071
$2,840.95
in general payments reported to CMS, 2019-2025
12 companies · $2,494 in 2025
The $2,494 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $346 · 2025: $2,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700 · Travel and Lodging: $985 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.27 |
| Travel and Lodging | $985.45 |
| Education | $155.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $1,281.71 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $688.24 | 2024-2025 | Dupixent |
| Genzyme Corporation | $265.65 | 2024-2025 | |
| Inspire Medical Systems, INC. | $228.63 | 2025 | Inspire |
| Spirair, INC. | $145.61 | 2025 | |
| Glaxosmithkline, LLC. | $65.97 | 2025 | Nucala |
| Hikma Pharmaceuticals USA | $40.91 | 2024-2025 | Ryaltris |
| Organogenesis INC. | $35.89 | 2025 | Affinity |
| Optinose US, INC. | $27.11 | 2025 | |
| Medtronic, INC. | $21.33 | 2024 | Ligasure |
| Phathom Pharmaceuticals, INC. | $20.07 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $19.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeline Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.